Over the past two decades, there has been a continuous increase in the incidence of head and neck squamous cell carcinoma (HNSCC) worldwide despite a decline in traditional risk factors, such as tobacco and alcohol use [1,2]. The HNSCC represents a spectrum of tumors, including the ones in the oral cavity, pharynx, nasal cavity, and larynx, which account for 6% of all malignant tumors, with more than 600,000 newly diagnosed cases of HNSCC worldwide every year [3,4]. The epidemiologic studies have implicated that persistent infection with high-risk Human papillomavirus (HR-HPV) could be a major risk factor and the likely etiologic agent for the subsequent development of HNSCC. Among the different HR-HPV types that can infect humans, HPV subtypes 16 and 18 are associated with approximately 70% of HNSCC cases [5,6]. There is an urgent requirement for the application of an HR-HPV detection method for primary screening in clinics for the treatment as well as describe the prognosis of HNSCC patients with potential for treatment selection based on tumor HPV status [7,8].Currently, there is no "gold standard" method for the diagnosis of HPV infection in a strict sense. The methods used still rely on molecular biology techniques from the late 1980s that use nucleic acid probes. These techniques have cumbersome operation; they use nucleic acid probes labeled with 32 P radioactive phosphorus; they are unable to confirm all carcinogenic HPV genotypes; thus, they have not been widely used in the early stages [9,10]. Commercial HPV detection kits (such as Hybrid Capture 2 kit developed by Qiagen Corporation) can detect almost all types of carcinogenic HR-HPVs, as well as most low-risk noncarcinogenic HPV genotypes [11]. However, due to patent protection, it is an expensive method. Besides, various PCR-based detection methods are also widely used for HPV detection, genotyping, and viral load determination. These methods include blot hybridization, Papillo Check, and quantitative real-time PCR (qRT-PCR). These methods have the ability to rapidly achieve the specified amplification to HPV and virus genotyping and can generate viral load (concentration) data from the reaction curve generated by RT-PCR reaction kinetics [10,12]. However, the PCR-There has been increasing interest in the head and neck squamous cell carcinoma (HNSCC) that is caused by high-risk human papillomavirus (HR-HPV) and has posed a significant challenge to Otolaryngologists. A rapid, sensitive, and reliable method is required for the detection of HR-HPV in clinical specimens to prevent and treat HPV-induced diseases. In this study, a multiple cross-linking spiral amplification (MCLSA) assay was developed for the visual detection of HPV-16. In the MCLSA assay, samples were incubated under optimized conditions at 62°C for 45 min, and after mixing with the SYBR Green I (SGI) dye, the positive amplicons showed bright green fluorescence while the negative amplicons exhibited no obvious change. The specificity test revealed that the developed MCLSA technique had hi...